Originally published June 11 2005
Children's Tylenol issues recall of softchews and meltaways products
by Mike Adams, the Health Ranger, NaturalNews Editor
Last week the makers of Children's Tylenol issued a voluntary recall of its 80-mg and 160-mg softchews and meltaways products. McNeil Consumer & Specialty Pharmaceuticals issued the recall because of confusing wording on the products' packaging that could lead to overdosing, though the company had no reports of overdosing.
The maker of Tylenol said Friday it is voluntarily recalling several children's products because label information may be confusing and could lead to overdosing.
McNeil Consumer & Specialty Pharmaceuticals said it is recalling all lots and all flavors of 80-milligram Children's Tylenol Meltaways packaged in bottles and blisters, 80-milligram Children's Tylenol SoftChews packaged in blisters, and 160-milligram Jr.
The recall affects only SoftChews and Meltaways versions of the product.
McNeil is a unit of health care products company Johnson & Johnson Inc. (Related: http://www.tylenol.com)
In 80-milligram products, the recall was triggered by concerns that blister packs containing two pills in each compartment would lead some consumers to believe that the two tablets contained a total of 80 milligrams of acetaminophen; each tablet contains 80 milligrams.
The company eliminated the double-pill blister cavity design for a single pill cavity design in the first quarter, McNeil spokeswoman Kathy Fallon said.
As for bottled products and the 160-milligram product, the company said that labeling on the front panel of the carton could confuse consumers on proper dosages.
The spokeswoman said McNeil was changing wording on the front of the package to say that each "tablet" contains the given strength of acetaminophen rather than each "dose."
In all cases, caregivers should follow the dosage directions in the medications' "Drug Facts" label or on the bottle label, Fallon said.
Fallon said the company was alerted to the possible confusion after receiving calls from consumers concerning proper dosing.
McNeil is launching a campaign to alert consumers about proper dosages.
The company said it notified the Food and Drug Administration of the voluntary recall.
Shares of Johnson & Johnson fell 46 cents, or 0.7%, to $66.54 in afternoon trading on the New York Stock Exchange.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml